Terug
Ook genoteerd als
MEOBF
OTC
Dagbereik
€ 14,07
€ 14,42
52-Weeksbereik
€ 9,61
€ 21,50
Volume
229.816
50D / 200D Gem.
€ 16,77
/
€ 15,78
Vorige Slotkoers
€ 14,02
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -18,0 | 0,3 |
| P/B | 3,1 | 2,9 |
| ROE % | -19,0 | 3,7 |
| Net Margin % | -593,9 | 3,8 |
| Rev Growth 5Y % | 23,2 | 10,0 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Hold
€ 11,50
-19.7%
Low: € 11,00
High: € 12,00
Forward WPA
-€ 0,30
Omzet Sch.
130 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,32
€ 2,78 – € 4,20
|
890 M | 1 |
| FY2029 |
€ 1,47
€ 1,23 – € 1,86
|
910 M | 1 |
| FY2028 |
€ 0,90
€ 0,75 – € 1,13
|
470 M | 1 |
Belangrijkste Punten
Revenue grew 23,24% annually over 5 years — strong growth
Debt/Equity of 0,21 — conservative balance sheet
Negative free cash flow of -50,68M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 168,15%
Capital efficient — spends only 4,24% of revenue on capex
Groei
Revenue Growth (5Y)
23,24%
Revenue (1Y)191,39%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-18,95%
ROIC-6,45%
Net Margin-593,92%
Op. Margin-363,08%
Veiligheid
Debt / Equity
0,21
Current Ratio1,99
Interest Coverage-2,72
Waardering
P/E Ratio
-18,04
P/B Ratio3,08
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 191,39% | Revenue Growth (3Y) | 51,42% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 23,24% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 17,20M | Net Income (TTM) | -102,14M |
| ROE | -18,95% | ROA | -13,02% |
| Gross Margin | 70,17% | Operating Margin | -363,08% |
| Net Margin | -593,92% | Free Cash Flow (TTM) | -50,68M |
| ROIC | -6,45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,21 | Current Ratio | 1,99 |
| Interest Coverage | -2,72 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -18,04 | P/B Ratio | 3,08 |
| P/S Ratio | 107,15 | PEG Ratio | 2,44 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,84B | Enterprise Value | 1,81B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 17,20M | 5,90M | 7,50M | 10,21M | 7,46M |
| Net Income | -102,14M | -87,96M | -81,89M | -91,35M | -98,81M |
| EPS (Diluted) | -0,84 | -0,89 | -0,98 | -1,30 | -1,60 |
| Gross Profit | 12,07M | -35,17M | -47,42M | -53,36M | -78,28M |
| Operating Income | -62,44M | -84,15M | -69,29M | -80,57M | -109,10M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 784,68M | 669,15M | 669,42M | 662,14M | 744,72M |
| Total Liabilities | 187,24M | 188,80M | 167,58M | 165,10M | 163,32M |
| Shareholders' Equity | 597,44M | 480,36M | 501,84M | 497,04M | 581,40M |
| Total Debt | 128,16M | 118,92M | 116,50M | 106,91M | 105,50M |
| Cash & Equivalents | 161,16M | 62,56M | 70,92M | 60,03M | 136,88M |
| Current Assets | 204,35M | 86,46M | 81,66M | 69,84M | 148,23M |
| Current Liabilities | 102,63M | 73,24M | 41,98M | 51,37M | 94,27M |